REGULGENT Trademark

Trademark Overview


On Wednesday, May 26, 2021, a trademark application was filed for REGULGENT with the United States Patent and Trademark Office. The USPTO has given the REGULGENT trademark a serial number of 79316567. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by Kyowa Kirin Co., Ltd.. The REGULGENT trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; Custom manufacturing, namely, contract , refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of custom manufacturing in the field of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; ...

Pharmaceuticals comprising monospecific, bispecific or multispecific antibodies, fragments of monospecific, bispecific or multispecific antibodies and derivatives of monospecific, bispecific or multispecific antibodies for medical purposes; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for medical purposes; cells for medical purposes

Development of antibodies, fragments of antibodies and derivatives of antibodies for others; development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for others; development of host cells for others; providing technical information in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; providing technical information in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies
regulgent

General Information


Serial Number79316567
Word MarkREGULGENT
Filing DateWednesday, May 26, 2021
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6816928
Registration DateTuesday, August 16, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesContract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; Custom manufacturing, namely, contract , refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of custom manufacturing in the field of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; providing technical information in the field of contract manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; technical consultation in the field of manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
Goods and ServicesPharmaceuticals comprising monospecific, bispecific or multispecific antibodies, fragments of monospecific, bispecific or multispecific antibodies and derivatives of monospecific, bispecific or multispecific antibodies for medical purposes; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for medical purposes; cells for medical purposes
Goods and ServicesDevelopment of antibodies, fragments of antibodies and derivatives of antibodies for others; development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for others; development of host cells for others; providing technical information in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; providing technical information in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyowa Kirin Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameKyowa Kirin Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameKyowa Kirin Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Wednesday, December 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 26, 2022FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 26, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 16, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 11, 2022REFUSAL PROCESSED BY IB
Friday, March 18, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 18, 2022REFUSAL PROCESSED BY MPU
Thursday, February 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 9, 2022ASSIGNED TO EXAMINER
Tuesday, August 10, 2021APPLICATION FILING RECEIPT MAILED
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 5, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 29, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB